ITMI20022412A1 - Peptidi immunogeni di ptprk. - Google Patents
Peptidi immunogeni di ptprk.Info
- Publication number
- ITMI20022412A1 ITMI20022412A1 IT002412A ITMI20022412A ITMI20022412A1 IT MI20022412 A1 ITMI20022412 A1 IT MI20022412A1 IT 002412 A IT002412 A IT 002412A IT MI20022412 A ITMI20022412 A IT MI20022412A IT MI20022412 A1 ITMI20022412 A1 IT MI20022412A1
- Authority
- IT
- Italy
- Prior art keywords
- ptprk
- immunogenic peptides
- diagnosis
- cells
- cancer immunotherapy
- Prior art date
Links
- 101000591201 Homo sapiens Receptor-type tyrosine-protein phosphatase kappa Proteins 0.000 title abstract 2
- 102100034089 Receptor-type tyrosine-protein phosphatase kappa Human genes 0.000 title abstract 2
- 230000002163 immunogen Effects 0.000 title abstract 2
- 108090000765 processed proteins & peptides Proteins 0.000 title abstract 2
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 210000001744 T-lymphocyte Anatomy 0.000 abstract 1
- 238000002619 cancer immunotherapy Methods 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
- C07K14/70503—Immunoglobulin superfamily
- C07K14/70539—MHC-molecules, e.g. HLA-molecules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/5743—Specifically defined cancers of skin, e.g. melanoma
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/515—Animal cells
- A61K2039/5154—Antigen presenting cells [APCs], e.g. dendritic cells or macrophages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/80—Vaccine for a specifically defined cancer
- A61K2039/876—Skin, melanoma
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/90—Enzymes; Proenzymes
- G01N2333/914—Hydrolases (3)
- G01N2333/916—Hydrolases (3) acting on ester bonds (3.1), e.g. phosphatases (3.1.3), phospholipases C or phospholipases D (3.1.4)
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Urology & Nephrology (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Food Science & Technology (AREA)
- Biophysics (AREA)
- Hospice & Palliative Care (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Epidemiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biotechnology (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Priority Applications (12)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002412A ITMI20022412A1 (it) | 2002-11-14 | 2002-11-14 | Peptidi immunogeni di ptprk. |
| PCT/EP2003/012638 WO2004043988A2 (en) | 2002-11-14 | 2003-11-12 | Ptprk immunogenic peptide |
| JP2004550996A JP2006506064A (ja) | 2002-11-14 | 2003-11-12 | Ｐｔｐｒｋ免疫原性ペプチド |
| EP03789032A EP1560848B1 (en) | 2002-11-14 | 2003-11-12 | Ptprk immunogenic peptide |
| AT03789032T ATE383371T1 (de) | 2002-11-14 | 2003-11-12 | Ptprk-immunogenes peptid |
| DK03789032T DK1560848T3 (da) | 2002-11-14 | 2003-11-12 | PTPRK-immunogent peptid |
| DE60318608T DE60318608T2 (de) | 2002-11-14 | 2003-11-12 | Ptprk-immunogenes peptid |
| AU2003293677A AU2003293677A1 (en) | 2002-11-14 | 2003-11-12 | Ptprk immunogenic peptide |
| PT03789032T PT1560848E (pt) | 2002-11-14 | 2003-11-12 | Péptido imunogénico de ptprk |
| US10/534,864 US20060159691A1 (en) | 2002-11-14 | 2003-11-12 | Ptprk immunogenic peptide |
| ES03789032T ES2299748T3 (es) | 2002-11-14 | 2003-11-12 | Peptido inmunogenico de ptpkr. |
| HK05108927A HK1076476A1 (en) | 2002-11-14 | 2005-10-10 | Ptprk immunogenic peptide |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT002412A ITMI20022412A1 (it) | 2002-11-14 | 2002-11-14 | Peptidi immunogeni di ptprk. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20022412A1 true ITMI20022412A1 (it) | 2004-05-15 |
Family
ID=32310164
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT002412A ITMI20022412A1 (it) | 2002-11-14 | 2002-11-14 | Peptidi immunogeni di ptprk. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20060159691A1 (it) |
| EP (1) | EP1560848B1 (it) |
| JP (1) | JP2006506064A (it) |
| AT (1) | ATE383371T1 (it) |
| AU (1) | AU2003293677A1 (it) |
| DE (1) | DE60318608T2 (it) |
| DK (1) | DK1560848T3 (it) |
| ES (1) | ES2299748T3 (it) |
| HK (1) | HK1076476A1 (it) |
| IT (1) | ITMI20022412A1 (it) |
| PT (1) | PT1560848E (it) |
| WO (1) | WO2004043988A2 (it) |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5863755A (en) * | 1993-04-21 | 1999-01-26 | Max Planck Gessellschaft | Nucleic acid encoding novel receptor-type phosphotyrosine phosphatase-κ |
-
2002
- 2002-11-14 IT IT002412A patent/ITMI20022412A1/it unknown
-
2003
- 2003-11-12 ES ES03789032T patent/ES2299748T3/es not_active Expired - Lifetime
- 2003-11-12 US US10/534,864 patent/US20060159691A1/en not_active Abandoned
- 2003-11-12 PT PT03789032T patent/PT1560848E/pt unknown
- 2003-11-12 WO PCT/EP2003/012638 patent/WO2004043988A2/en active IP Right Grant
- 2003-11-12 AT AT03789032T patent/ATE383371T1/de not_active IP Right Cessation
- 2003-11-12 JP JP2004550996A patent/JP2006506064A/ja active Pending
- 2003-11-12 AU AU2003293677A patent/AU2003293677A1/en not_active Abandoned
- 2003-11-12 DE DE60318608T patent/DE60318608T2/de not_active Expired - Fee Related
- 2003-11-12 DK DK03789032T patent/DK1560848T3/da active
- 2003-11-12 EP EP03789032A patent/EP1560848B1/en not_active Expired - Lifetime
-
2005
- 2005-10-10 HK HK05108927A patent/HK1076476A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| US20060159691A1 (en) | 2006-07-20 |
| DK1560848T3 (da) | 2008-05-26 |
| DE60318608T2 (de) | 2009-01-15 |
| EP1560848B1 (en) | 2008-01-09 |
| ES2299748T3 (es) | 2008-06-01 |
| AU2003293677A1 (en) | 2004-06-03 |
| WO2004043988A3 (en) | 2004-10-14 |
| DE60318608D1 (de) | 2008-02-21 |
| JP2006506064A (ja) | 2006-02-23 |
| HK1076476A1 (en) | 2006-01-20 |
| PT1560848E (pt) | 2008-04-08 |
| WO2004043988A2 (en) | 2004-05-27 |
| ATE383371T1 (de) | 2008-01-15 |
| EP1560848A2 (en) | 2005-08-10 |
| WO2004043988A8 (en) | 2005-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1113044T1 (el) | Παραλλαγματα αντιγονου αρχεγονων κυτταρων προστατη (psca) και υποαλληλουχιες εξ αυτων | |
| ATE460176T1 (de) | Mikrosomvakzin | |
| PE20040554A1 (es) | Vacunas que comprenden proteinas de fusion | |
| CY1114855T1 (el) | Αντισωματα και μορια που προερχονται απο αυτα που δεσμευονται στις πρωτεϊνες toy steap-1 | |
| CR8231A (es) | Anticuerpos rg1 y uso de los mismos | |
| EA200501206A1 (ru) | Производные от сурвивина пептиды и их применение | |
| DK0810870T3 (da) | Isolerede, MAGE-2-afledte tumorafstødelsesantigenpræcurserpeptider og anvendelse heraf | |
| WO2002064057A3 (en) | Use of cell penetrating peptides to generate antitumor immunity | |
| CY1107706T1 (el) | Πεπτιδια ανταγωνιστες καρκινοεμβρυονικου αντιγονου (cea) | |
| WO2005058937A3 (en) | A human cytotoxic t-lymphocyte epitope and its agonist epitope from the non-variable number of tandem repeat sequence of muc-1 | |
| UA97092C2 (ru) | T-клеточные эпитопы с раково-эмбрионального антиген-незрелого рецепторного белка ламинина и их медицинское применение | |
| DE60331224D1 (de) | Subtilisin-carlsberg-proteine mit verminderter immunogenität | |
| TR200102034T2 (tr) | Anti kanser aşılaması için antikorların kullanılması | |
| EA200600738A1 (ru) | Способ | |
| DE60118359D1 (de) | Humanische pellino-polypeptide | |
| WO2004030616A3 (en) | Ii-KEY/ANTIGENIC EPITOPE HYBRID PEPTIDE VACCINES | |
| Cornet et al. | Optimal organization of a polypeptide-based candidate cancer vaccine composed of cryptic tumor peptides with enhanced immunogenicity | |
| DE69720065D1 (de) | Therapeutische anwendungen von antigenen oder epitopen assoziert mit unvollständiger zellulärer peptidprozesierung , z.b.: exprimiert in rma-s zellen transfiziert mit b7-1 gen | |
| AU7615900A (en) | Isolated peptides which bind to mhc class ii molecules, and uses thereof | |
| ITMI20022412A1 (it) | Peptidi immunogeni di ptprk. | |
| WO2003106616A3 (en) | $ G (B) MICROGLOBULIN MEMBRANE ANCHORED COVALENTLY LINKED TO PEPTIDE EPITOPES OF CLASS I MHC | |
| AU2003245781A1 (en) | Mhc class ii peptide epitope of 5t4 antigen | |
| EP2193804A3 (en) | Recombinant adenylate cyclase toxin of bordetella induces T cell responses against tumoral antigens | |
| HUP0300997A2 (hu) | A MIA-fehérje alkalmazása immunterápiában | |
| PT996636E (pt) | Antigenio ha-1 |